In the present study, we designed a screen of STAT3/CCND2 inhibitors, through which a novel small molecule compound called SC99 was found to inhibit STAT3 via JAK2, a kinase that activates STAT3, and displayed oral potency in the treatment of MM. The gene discussed is JAK2; the disease is Miyoshi myopathy.